A Preventative Health Software Company

We make smart tools that reduce the instance and impact of infectious disease.

Using a hybrid-funding model of venture capital and public-sector investment, Pandemic Insights is combining machine learning with human behavior dynamics to power a platform that helps individuals, organizations, and public health agencies see and manage hyperlocal infection risk.

Products will always include a free version of the mobile app delivered without user tracking or ads, in keeping with Pandemic Insights’s core values of privacy, access, choice, and transparency.

question mark

Why We Exist

To reduce the instance and impact of
infectious disease.
star icon

How We Do It

Create tools that let people know and
manage hyperlocal health risk.
exclamation mark

The World We Want

A pandemic-free planet.

person taking picture at concert

What We Stand For

To learn more, click on a letter below.

constellation like connection of dots

The Pandemic Insights Team

Eric Klasson

Pandemic Insights Founder and CEO

Mr. Klasson is an experienced entrepreneur and C-level executive responsible for leading multiple technology start-ups and companies through significant growth over his 35-year career. His early career included tenure at Price Waterhouse, PepsiCo, ConAgra and FoxMeyer Corporation. For the past decade, he has successfully focused on developing AI and machine learning technology solutions. Klasson specializes in technology commercialization, public/private research partnerships, and non-dilutive strategic partner financings. He has completed private and public debt and equity financings and has significant business development experience in international technology commercialization. His leadership roles include CFO, COO, President, and CEO.

Eric has served on multiple boards of non-profit and for-profit organizations. Eric received a Bachelor in Economics from the University of Michigan, an MBA from Texas A&M University, and completed USC’s Pharmaceutical Industry Executive Development Program. Eric has been actively involved in addressing food insecurity issues for over two decades. His work in this area includes non-profit director positions with the Monterey County Food Bank, Mobile Loaves & Fishes, and the Capital Area Food Bank and Capital Area Food Bank Foundation, where he served as its Chairman.

Headshot of Eric Klasson

Robert Campbell

Pandemic Insights Director

Mr. Campbell is founder and CEO of Campbell Global Service LLC. Campbell serves as Interim Chairman of the Board Executive Committee of the global East West Institute, the Lyndon Johnson School of Public Affairs, Austin Foreign Affairs Council, Access Health Care, Texas 2036, The Global Leaders Organization, and Tractus Corporation. Campbell previously spent 39 years with Deloitte & Touche, where he was a partner for 32 years, led the firm’s Public Sector practice for many years, co-founded the firm’s federal consulting practice, co-founded the firm’s Center for Health Innovation and Center for Cyber Solutions, and was a vice chairman of the firm. Campbell also served on the U.S. Federal Debt Commission of the Bipartisan Policy Center. Mr. Campbell holds a BA degree with honors from Austin College, where he is in the Athletic Hall of Honor, and an MPA degree from the University of Texas at Austin’s LBJ School of Public Affairs, where he was the 2013 Distinguished Public Service Award honoree.

Barry Burgdorf

Pandemic Insights Director

Mr. Burgdorf is a partner at Hogan Lovells and has a multifaceted corporate practice in life sciences/biotech, healthcare, IT, software, and other technology markets as well as servicing clients in the higher education industry. As Vice-Chancellor and General Counsel of the University of Texas System for 9 years, Burgdorf regularly led its interactions with the federal government and oversaw areas that included legal, real estate, IT security, and technology transfer while serving as a member of UTS’s executive leadership team. He has been general counsel, outside counsel, and a c-level leader for both a life sciences and biotech venture capital fund and has served on numerous governing and advisory boards of technology and life sciences companies. Burgdorf holds a BA degree in finance and international business from the University of Texas at Austin, an MBA from Southern Methodist University, and a JD from the University of Texas School of Law.

Dr. Stephen Klasson, MD

Pandemic Insights Director

Dr. Klasson practices at Harbin Clinic, where he has been a Board Certified Orthopedic Hand Surgeon for 28 years. He has held multiple leadership roles, including serving as director on the boards of Harbin Clinic, Heritage First Bancshare, Surgery Center of Rome, and Harbin Properties. Since 1996, Dr. Klasson has been a member of both the American Society for Surgery of the Hand and the American Academy of Orthopaedic Surgeons. He holds a BA degree in History from Duke University and an MD from Vanderbilt University. Klasson is an investor in multiple privately-held manufacturing, professional services, and finance companies. He is also president of Health Creek Farm, LLC.

Headshot of Stephen Klasson

Tracey Davies

Pandemic Insights Director

Ms. Davies is Chief Strategic Initiatives and Chief Intellectual Property Officer at Cancer Prevention and Research Institute of Texas. She has more than 20 years of experience advising life science companies at all stages of development, and research institutions, across a broad range of business and legal issues.  Ms. Davies has represented clients in State and Federal Courts and in front of administrative tribunals throughout the United States, and has advised clients and led interdisciplinary trial teams managing disputes on a global basis.  She is also a licensed patent attorney,

Ms. Davies has substantial law firm management experience and has served at all levels of firm management, leading law firm business and practice development efforts.  Prior to joining CPRIT, she was a partner with Gibson Dunn & Crutcher L.L.P., where she co-chaired the firm’s Life Sciences industry practice. Previously, Davies was a partner and member of the Executive Management Committee at Vinson & Elkins, L.L.P., where she led the firm’s Intellectual Property, Technology and Life Science practices. Ms. Davies also serves on several non-profit and academic advisory councils, including for the Center for Entrepreneurial and Economic Innovation at the University of Texas at Arlington.

Davies received her J.D. from the University of Minnesota, where she also earned a master’s degree in Public Health. 

Harry Bushong

Pandemic Insights Director

Mr. Bushong is Founder and Managing Director of Convergence Ventures, a venture capital fund dedicated to driving growth and development of leading-edge software-based solutions in healthcare, life sciences, and artificial intelligence. In 2005, he co-founded nanoTox, Inc. to focus on providing toxicology services for companies using nano-scale technology across a wide range of industries. nanoTox has since morphed into Material Intellect, a new company that uses machine learning and other advanced tools to enhance the research capabilities of corporations, as well as academic and government laboratories. Harry has been an active investor in Advanced Throughput, Inc., a genomics company focused on personalized medicine (acquired by privately-held Bastra, Ltd.) and Optokey, Inc., a bio-spectroscopic and environmental analysis company.

Headshot of Harry Bushong

Follow Our Progress.